In a large prospective multicenter study, a 12-miRNA panel for the detection of GC has been developed and has been demonstrated to outweigh the diagnostic accuracy of other non-invasive methods for the diagnosis of GC (AUC 0.84 versus 0.63 of Hp serology, 0.64 of ABC method) [45]. The gene discussed is HP; the disease is gastric cancer.